NeoGenomics’ PanTracer LBx Test Qualifies for Medicare Coverage Under MolDX Policy
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Latest Articles
Editor's Top Picks
Deep Learning Pathology Models Caught ‘Cheating,’ Study Finds
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
New Portable FeNO Device Enables Six-Second Breath Test for Respiratory Assessment
The handheld system supports point-of-care fractional exhaled nitric oxide testing in adults and pediatric patients.
Equipment & Supply Spotlight
Quest Diagnostics Launches AI Tool to Help Patients Interpret Lab Results
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
News, Know-How & Standards
Disease Detection & Understanding
Walgreens Partners to Expand Colorectal Cancer Screening Access
The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.
